Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs enalapril in pediatric hypertension (12-week MSSBP non-inferiority)
2006-005260-88Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of valsartan in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Change from baseline in mean sitting systolic blood pressure at week 12. Started Feb 2007; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2006-005260-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005260-88.